2 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Solumedrol: new trials by email Literature Review of Solumedrol trials Research Report on Solumedrol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone Methylprednisolone, ACTH, IV placebo - Multiple Sclerosis | Phase 2 / Phase 3 | Terminated | Neurologique Foundation, Inc. | 30 | 2009-10-01 | 2016-03-22 |
| Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML Allogeneic HSCT, Anti-thymocyte globulin (ATG), Cyclosporine (CSP) - Leukemia, Myeloid, Leukemia | Phase 3 | Terminated | Stanford University | 58 | 2007-08-01 | 2019-09-24 |
Leukemia (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1) · Multiple Sclerosis (1) · Recurrence (1) · Sclerosis (1)
Neurologique Foundation, Inc. (1) · Stanford University (1)
United States (2)
Daniel Kantor, MD (1) · Robert Lowsky (1)